Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to $247159.0.

  • Creative Medical Technology Holdings' Accounts Payables fell 972.81% to $247159.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $247159.0, marking a year-over-year decrease of 972.81%. This contributed to the annual value of $273530.0 for FY2024, which is 1378.91% down from last year.
  • Creative Medical Technology Holdings' Accounts Payables amounted to $247159.0 in Q3 2025, which was down 972.81% from $263450.0 recorded in Q2 2025.
  • In the past 5 years, Creative Medical Technology Holdings' Accounts Payables ranged from a high of $3.3 million in Q4 2022 and a low of $247159.0 during Q3 2025
  • For the 5-year period, Creative Medical Technology Holdings' Accounts Payables averaged around $502655.9, with its median value being $335681.0 (2022).
  • As far as peak fluctuations go, Creative Medical Technology Holdings' Accounts Payables skyrocketed by 32888.84% in 2022, and later tumbled by 9028.99% in 2023.
  • Creative Medical Technology Holdings' Accounts Payables (Quarter) stood at $761862.0 in 2021, then skyrocketed by 328.89% to $3.3 million in 2022, then tumbled by 90.29% to $317280.0 in 2023, then dropped by 13.79% to $273530.0 in 2024, then fell by 9.64% to $247159.0 in 2025.
  • Its Accounts Payables stands at $247159.0 for Q3 2025, versus $263450.0 for Q2 2025 and $272193.0 for Q1 2025.